| 000 | 01718 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514033443.0 | ||
| 264 | 0 | _c20021203 | |
| 008 | 200212s 0 0 eng d | ||
| 022 | _a0903-1936 | ||
| 024 | 7 |
_a10.1183/09031936.02.00240902 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAalbers, R | |
| 245 | 0 | 0 |
_aFormoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial. _h[electronic resource] |
| 260 |
_bThe European respiratory journal _cMay 2002 |
||
| 300 |
_a936-43 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBronchodilator Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDiagnostic Techniques, Respiratory System |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aEthanolamines _xadministration & dosage |
| 650 | 0 | 4 | _aExercise Test |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFormoterol Fumarate |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdrug therapy |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSpirometry |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aAyres, J | |
| 700 | 1 | _aBacker, V | |
| 700 | 1 | _aDecramer, M | |
| 700 | 1 | _aLier, P A | |
| 700 | 1 | _aMagyar, P | |
| 700 | 1 | _aMalolepszy, J | |
| 700 | 1 | _aRuffin, R | |
| 700 | 1 | _aSybrecht, G W | |
| 773 | 0 |
_tThe European respiratory journal _gvol. 19 _gno. 5 _gp. 936-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1183/09031936.02.00240902 _zAvailable from publisher's website |
| 999 |
_c11928182 _d11928182 |
||